BioGaia AB (publ) (0GTN.IL)

134.50 +1.40 (+1.05%) At close: 04:51PM BST

BioGaia AB (publ)

Kungsbroplan 3
Stockholm 112 27
Sweden
46 8 55 52 93 00
https://www.biogaia.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 212

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Peter Rothschild M.Sc. Econ., MBA	Founder & Chairman	1.3M	N/A	1950
Mr. Alexander Kotsinas M.Sc. (Eng.).	Exec. VP & CFO	2.98M	N/A	1967
Ms. Theresa P. Agnew	CEO & Pres	N/A	N/A	N/A
Ludvig Milesson	Chief Operating Officer	N/A	N/A	1977
Mr. Gianfranco Grompone	Chief Scientific Officer and VP of R&D	N/A	N/A	1975
Ms. Caroline Mofors	Chief Legal Officer	N/A	N/A	1972
Ms. Linda Hagglund	VP of Marketing	N/A	N/A	1973
Ms. Angelika Kjelldorff	Chief HR Officer	N/A	N/A	1969
Sebastian Heimfors	VP & Chief Commercial Officer	N/A	N/A	1974
Jonathan Gromark	Sustainability Mang.	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylori–the gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Corporate governance

BioGaia AB (publ)’s ISS governance QualityScore as of 1 October 2023 is 9. The pillar scores are Audit: 9; Board: 7; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.